Drug Type Small molecule drug |
Synonyms allicin |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC6H10OS2 |
InChIKeyJDLKFOPOAOFWQN-UHFFFAOYSA-N |
CAS Registry539-86-6 |
Start Date12 May 2025 |
Sponsor / Collaborator- |
Start Date01 Mar 2025 |
Sponsor / Collaborator |
Start Date21 Dec 2024 |
Sponsor / Collaborator |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diarrhea | China | - | - |
Feeding and Eating Disorders | China | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Fibrosis | Preclinical | China | 30 May 2025 | |
Pulmonary Fibrosis | Preclinical | Japan | 30 May 2025 | |
Liver Cancer | Preclinical | China | 01 Jun 2024 | |
Philadelphia chromosome positive chronic myelogenous leukemia | Preclinical | United States | 07 Dec 2017 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |